Commentary
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)
Mark Levine and The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ January 23, 2001 164 (2) 213;
Mark Levine
Dr. Levine is with the Cancer Care Ontario Hamilton Regional Cancer Centre, the Departments of Medicine and of Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffett Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. The steering committee is part of Health Canada's Canadian Breast Cancer Initiative.
Dr. Levine is with the Cancer Care Ontario Hamilton Regional Cancer Centre, the Departments of Medicine and of Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffett Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont. The steering committee is part of Health Canada's Canadian Breast Cancer Initiative.
Article Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)
Mark Levine, The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ Jan 2001, 164 (2) 213;
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)
Mark Levine, The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ Jan 2001, 164 (2) 213;